He has more than 30 uears of board, corporate, finance and accounting leadership, according to a news release shared with Becker’s. His past experience includes at Calyxt, Medtronic and Young America Holdings.
Mr. Koschak is replacing former SynerFuse CFO Dennis McFadden, who is retiring and will have an strategic advisory role with the company.
SynerFuse focuses on treating back pain associated with spinal fusion.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
